| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |